2020 ASCO Virtual Direct™ Highlights
2020 ASCO Update on 1st Line IO Strategies for Metastatic NSCLC: Should CheckMate 227 (Ipi + Nivo) and CheckMate 9LA (Nivo/Ipi + Chemo) Data Change My Practice? Tiragolumab/Atezolizumab Shows Promising Activity in PD-L1+ NSCLC
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Ibiayi Dagogo-Jack
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Ibiayi Dagogo-Jack
Login to view comments.
Click here to Login
